cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biocryst Pharmaceuticals Inc
46 own
51 watching
Current Price
$7.35
$0.19
(2.65%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,664.06M
52-Week High
52-Week High
14.50000
52-Week Low
52-Week Low
6.62000
Average Volume
Average Volume
1.95M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,664.06M
icon52-Week High14.50000
icon52-Week Low6.62000
iconAverage Volume1.95M
iconDividend Yield--
iconP/E Ratio--
What does the Biocryst Pharmaceuticals Inc do?
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. The company markets peramivir, an intravenous neuraminidase inhibitor, which is approved for uncomplicated seasonal and acute influenza in the United States and Canada under the name RAPIVAB, in Japan and Taiwan as RAPIACTA, and in Korea as PERAMIFLU. It also has various ongoing development programs, including BCX7353 and second generation oral inhibitors of plasma kallikrein for hereditary angioedema; and galidesivir, a broad spectrum viral RNA polymerase inhibitor that is indicated to treat filoviruses, as well as forodesine, an oral purine nucleoside phosphorylase inhibitor for use in oncology. It has collaborative relationships with Mundipharma International Holdings Limited for the development and commercialization of forodesine; Shionogi & Co., Ltd. and Green Cross Corporation for the development and commercialization of peramivir in Japan, Taiwan, and South Korea; Seqirus UK Limited for the development and commercialization of RAPIVAB worldwide, except Japan, Taiwan, Korea, and Israel; and the University of Alabama at Birmingham for the development of influenza neuraminidase and complement inhibitors. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Read More
How much money does Biocryst Pharmaceuticals Inc make?
News & Events about Biocryst Pharmaceuticals Inc.
Stock Options Channel
2 months ago
Investors in BioCryst Pharmaceuticals Inc (BCRX) saw new options begin trading this week, for the July 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
PR Newswire
4 months ago
Thinking about buying stock in ImmunoGen, Mersana Therapeutics, Unisys, Eyepoint Pharmaceuticals, or BioCryst Pharmaceuticals? Thinking about buying stock in ImmunoGen, Mersana Therapeutics, Unisys, Eyepoint Pharmaceuticals, or BioCryst Pharmaceuticals? PR Newswire NEW YORK, May 3, 2023 NEW YORK...
Globe Newswire
5 months ago
RESEARCH TRIANGLE PARK, N.C., April 12, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the following investor conferences: The 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19th at 8:45 a.m. ET The BofA ...
Globe Newswire
5 months ago
RESEARCH TRIANGLE PARK, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Dr. Nancy Hutson as chair of its board of directors, effective immediately. I am honored to succeed Bob Ingram. He was a model of effective board ...
Frequently Asked Questions
Frequently Asked Questions
What is Biocryst Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Biocryst Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Biocryst Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Biocryst Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Biocryst Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Biocryst Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Biocryst Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Biocryst Pharmaceuticals Inc?
plus_minus_icon
What percentage is Biocryst Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Biocryst Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$7.35
$0.19
(2.65%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$8.85
$-0.18 (-1.99 %)
Vericel Corporation
Vericel Corporation
$34.00
$-0.19 (-0.56 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$6.89
$-0.08 (-1.15 %)
AxoGen, Inc.
AxoGen, Inc.
$4.88
$-0.11 (-2.20 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$8.85
$-0.18 (-1.99 %)
Vericel Corporation
Vericel Corporation
$34.00
$-0.19 (-0.56 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$6.89
$-0.08 (-1.15 %)
AxoGen, Inc.
AxoGen, Inc.
$4.88
$-0.11 (-2.20 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00